Literature DB >> 7913046

Adrenergic modulation of the blood neutrophilia induced by platelet activating factor in rats.

S P Altenburg1, P T Bozza, M A Martins, E V Tibiriçá, P M Silva, R S Cordeiro, H C Castro-Faria-Neto.   

Abstract

The involvement of catecholamines in blood neutrophilia observed after administration of platelet activating factor (PAF) to rats was studied. Intravenous (i.v.) injection of PAF (4 micrograms/kg) into naive rats more than doubled the number of neutrophils after 1 h. In contrast, PAF failed to induce neutrophilia in both adrenalectomized rats and those which had their catecholamine stores depleted by reserpine. PAF-induced neutrophilia was not inhibited by the selective antagonism of alpha 1- and alpha 2-adrenoceptors with prazosin and yohimbine, respectively. However, pretreatment with the beta-adrenoceptor antagonist, propranolol, significantly inhibited the phenomenon. Increase in the blood neutrophil counts was also achieved following the i.v. injection of the beta-agonist, salbutamol (1 mg/kg, i.v.). This response was clearly sensitive to propranolol but was not modified in rats submitted to adrenalectomy or reserpine pretreatment. The results suggest that the blood neutrophilia induced by the i.v. administration of PAF in rats is dependent on the stimulation of beta-adrenoceptors by catecholamines released from adrenal glands.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913046     DOI: 10.1016/0014-2999(94)90614-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Cyclic AMP elevating agents and nitric oxide modulate angiotensin II-induced leukocyte-endothelial cell interactions in vivo.

Authors:  A Alvarez; L Piqueras; M A Blazquez; M J Sanz
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

2.  In vitro and in vivo effects of salbutamol on neutrophil function in acute lung injury.

Authors:  G D Perkins; N Nathani; D F McAuley; F Gao; D R Thickett
Journal:  Thorax       Date:  2006-08-23       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.